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Objective To assess the molecular epidemiology and risk factors of predominant clones
and sporadic strains of methicillin-resistant Staphylococcus aureus (MRSA) in Swiss
hospitals and to compare them with European strains of epidemic clones.
Material and methods One-year national survey of MRSA cases. Analysis of epidemio-
logical and molecular typing data (PFGE) of MRSA strains.
Results In1997,385casesofMRSAwererecordedinthefiveSwissuniversityhospitalsand
in 47 community hospitals. Half of the cases were found in Geneva hospitals where MRSA
was already known to be endemic. Molecular typing of 288 isolates (one per case) showed
that 186 (65%) belong to four predominant clones, three of which were mostly present in
Geneva hospitals. In contrast, the fourth clone (85 cases) was found in 23 hospitals (in one to
16 cases per hospital). The remaining 35% of the strains were clustered into 62 pulsed field
gel electrophoresis types. They accounted for one to five patients per hospital and were
defined as sporadic. Multivariate analysis revealed no independent risk factors for harbor-
ing a predominant versus a sporadic strain, except that transfer from a foreign hospital
increases the risk of harboring a sporadic strain (OR, 42; 95% CI, 5–360).
Conclusion While cases with predominant clones were due to the local spread of these
clones, most sporadic cases appear to be due to the continuous introduction of new
strains into the country. With the exception of a transfer from a hospital outside
Switzerland, no difference in the clinical or epidemiological characteristics was observed
between patients harboring a predominant clone and those with a sporadic strain.
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I N T R O D U C T I O N
Staphylococcus aureus strains that are resistant to
methicillin (MRSA), are frequently resistant to
many other classes of antibiotics and are one of
the greatest challenges for modern antimicrobial
chemotherapy, especially with the emergence of S.
aureus with intermediate susceptibility to glyco-
peptides in Japan [1]. In the early 1990s, a Eur-
opean survey indicated that MRSA tended to be
more frequent in southern than in northern Eur-
ope. In countries such as France, Spain and Italy
more than 30% of hospital isolates of S. aureus were
resistant to methicillin [2]. However, within a
country, this proportion may vary substantially
from one hospital to another [3].
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The epidemiology of MRSA has been investi-
gated using molecular typing methods in many
surveys at the hospital level and in some studies at
a regional or national level [4–10]. Most of these
studies have shown that predominant or epidemic
clones accounted for the majority of MRSA cases.
Many studies were focused on the investigation of
the spread of predominant clones, but relatively
little information is available on those strains
which are considered ‘sporadic’.
Although the reported proportion of S. aureus
being resistant to methicillin in countries sur-
rounding Switzerland is high, low proportions
(0–4%) have been reported in Swiss hospitals,
except in Geneva hospitals where rates in the
range of 20% over several years have been
reported [11,12]. The objective of the present study
was twofold: first, to establish the frequency and
the diversity of MRSA strains isolated in Switzer-
land, in order to identify predominant clones and
to compare them with predominant clones of
MRSA from surrounding countries; secondly, to
investigate possible epidemiological differences
between cases harboring predominant or sporadic
MRSA strains, in order to plan prevention and
education.
M A T E R I A L S A N D M E T H O D S
General setting and organization of the survey
In Switzerland, five university hospitals serve as
tertiary-care centers for a country of 7 million
inhabitants. In 1997, these centers participated in
a national survey of MRSA. Each center was
responsible for gathering data and collecting iso-
lates from its own hospital and from community
hospitals in its vicinity that agreed to participate.
MRSA detection and control measures at the
hospital level
Surveillance and control measures used in the
participating institutions were standardized for
the purpose of the study [13]. In short, patients
with MRSA were identified by surveillance of
microbiological laboratory data from clinical spe-
cimens as well as by cultures obtained from
patients who were room-mates of patients infected
or colonized with MRSA. When a cluster was
suspected, patients on the ward as well as staff
were screened. In addition, surveillance cultures
were performed on readmitted of patients pre-
viously known to have been positive for MRSA
and on patients transferred from foreign hospi-
tals. Cultured sites included at least the anterior
nares, perineum and infected sites such as open
wounds.
Bacterial isolates
MRSA isolates were sent by the microbiology
laboratories of the participating hospitals to the
university centers. For all isolates, identification of
S. aureus was confirmed by standard methods and
susceptibility testing was performed by disk diffu-
sion on Mueller–Hinton agar with 24-h incubation
at 35 8C. Interpretation criteria were those of the
National Committee for Clinical Laboratory Stan-
dards (NCCLS) [14]. Resistance to oxacillin was
confirmed by the screen agar test [15] and on a
subset of isolates by amplification of the mecA
gene.
In addition, 40 European MRSA strains, repre-
senting 20 epidemic clones, were obtained from
different countries (see ref. [16] for more details) in
order to compare Swiss isolates with European
epidemic clones.
Molecular typing
Isolates were typed by pulsed field gel electro-
phoresis (PFGE) after SmaI DNA digestion using a
CHEF III apparatus (BioRad, Hercules, CA) as
already described [17]. The banding pattern of
the different gels was analyzed with the software
GELCOMPAR (Applied Maths, Ghent, Belgium).
Considering the stability of the PFGE patterns of
MRSA over a short period of time [17], isolates
showing an indistinguishable PFGE pattern were
assigned to a type and numbered. When more than
ten isolates from the same hospital showed an
indistinguishable pattern, they were considered
as belonging to a predominant clone. Isolates
showing patterns related (one to six band differ-
ences) to the pattern of the predominant strain
were considered as subtypes and labelled with a
letter. The predominant type and its subtypes
were considered as belonging to the same clone
[18,19].
Epidemiological data, definitions and statistics
A case was defined as a hospitalized patient found
to be infected or colonized with MRSA during
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the study period. For each case, the following
characteristics and risk factors for MRSA coloniza-
tion/infection were recorded: demographics, geo-
graphic origin, admission and discharge dates,
prior hospitalization during the preceding 3 years,
past history of MRSA colonization or infection, co-
morbidities (Charlson score [20]), functional status
(Karnofsky index [21]), underlying diagnosis,
infection versus colonization with MRSA, indwel-
ling catheter, wound, antibiotic treatment, drains,
intubation and operation.
Nosocomial clusters were defined as two or
more patients who were hospitalized in the same
ward within a 6-month period and who harbored
MRSA isolates which were indistinguishable by
molecular typing.
Standard definitions of the Centers for Diseases
Control and Prevention for the diagnosis of noso-
comial infections were used [22].
Variables with a significant Odd Ratio (OR) in
the univariate analysis were candidates for multi-
variate analysis. Multivariate modelling was per-
formed by using stepwise logistic regression
analysis. All statistical tests were two-tailed. OR
differences of unity were considered significant
when the 95% confidence interval did not overlap
with unity. Statistics were run on SPSS 8.0 (SPSS Inc,
Chicago, IL, USA).
R E S U L T S
Between January and December 1997, 359 cases of
MRSA were identified in the five university hos-
pitals and in 39 community hospitals throughout
the country. Half the cases were reported from the
university hospitals of Geneva (4.8 prevalent
cases/1000 admissions). The remaining cases were
distributed among 43 hospitals (0.16–0.97 preva-
lent cases/1000 admissions for university hospi-
tals and a mean of 0.68 prevalent cases/1000
admissions for community hospitals) throughout
the rest of Switzerland. Epidemiological data and
MRSA isolates were available for 225 (63%) of the
cases, whereas only epidemiological data or iso-
lates were available for 71 and 63 cases, respec-
tively.
Molecular typing (PFGE) of 288 isolates (one
isolate per case) indicated that 65% belonged to
four genetically different clones (Figure 1). Three
clones (GE1, GE2 and GE3) were found to be
predominant in Geneva university hospitals
where they accounted for 73% (108/148) of the
cases. Among 51 patients harboring clone GE1, 41
were hospitalized in Geneva University hospitals
and 10 in six other hospitals. Clone GE2 was
present in 20 patients in Geneva hospitals and
in six patients from five other hospitals. Finally,
clone GE3 was recovered from 26 patients hospi-
talized only in Geneva university hospitals. Thus,
the majority of the isolates of these three clones
(83%) were identified in Geneva hospitals. In con-
trast, the fourth predominant clone (85 cases) was
identified in 23 different hospitals (one to 16 cases
per hospital) from western Switzerland (clone
WCH) (Figure 2). The remaining 35% of the strains
represented 66 PFGE types and accounted for
clusters of only one to five patients per hospital,
and thus were considered sporadic.
Risk factors for MRSA colonization/infection
with a sporadic strain vs. a predominant clone
(GE1, GE2, GE3, WCH) were investigated by uni-
variate analysis (Table 1). Transfer from a foreign
hospital, previous acquisition of MRSA, hospita-
lization in a community hospital and the presence
of a drain or intubation were all factors increasing
the risk of harboring a sporadic strain. In contrast,
a higher co-morbidity index (Charlson score 4)
and hospitalization in a long-term care or rehabi-
litation center increased the risk of harboring a
predominant clone. These significant factors were
all included in the multivariable logistic regression
model (Table 2). Only the transfer from a foreign
hospital was independently associated with the
carriage of a sporadic strain (OR, 42; 95% CI,
5–360).
Comparison of Swiss MRSA isolates and
European epidemic clones
Forty strains from 20 epidemic clones of MRSA,
most of them from Europe, were analysed by
PFGE and compared with the 288 Swiss isolates
(Figure 3). The results confirmed that the clone
WCH was indistinguishable from the Belgian
clone 2 [16,23] and was related to the Ontario
epidemic clone (Canada) [24]. The clone GE1
was genetically related to the Belgian clone 1 (four
bands different) [23], to the North Germany phage
group III clone [4], and the Portuguese clone I::E::A
[25]. The clone GE2 was probably related to the
UK EMRSA 16 (two bands different), and the
clone GE3 has never been isolated elsewhere in
Switzerland and was found to be related to none of
the European clones analyzed.
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Figure 1 Distribution of PFGE types in community and university hospitals (Basel, Bern, Geneva, Lausanne and Zurich) (one strain per case). The four predominant
clones (WCH, GE1, GE2 and GE3) are represented by their major type (1, 9, 40 and 57, respectively) and their subtype (letters). All the other types are unique PFGE
patterns.
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Table 1 Risk factors for MRSA colonization/infection with a sporadic strain of MRSA versus a predominant clone (GE1,
GE2, GE3, or WCH): univariate analysis
Sporadica (%) Predominanta (%) Odds ratio CI95
b
Sex (F/M) 40/53 74/112 0.86 0.53–1.45
Origin (%):
home 36/79 (46) 75/114 (66) Reference
nursing home 6/79 (8) 12/114 (11) 1.03 0.38–2.77
transfer from Swiss hospital 12/79 (15) 21/114 (18) 1.19 0.51–2.76
transfer from foreign hospital 25/79 (32) 6/114 (5) 8.56 3.23–22.73
Prior hospitalization 73/80 (91) 123/136 (90) 1.10 0.42–2.89
Previous acquisition of MRSA 81/101 (80) 99/165 (60) 2.70 1.51–4.82
Infections with MRSA 51/98 (52) 64/126 (51) 1.20 0.69–2.07
Blood catheter 44/68 (65) 80/131 (61) 1.04 0.57–1.89
Indwelling urinary catheter 30/68 (44) 57/131 (44) 1.03 0.57–1.85
Woundc and ulcer 44/61 (72) 62/101 (61) 1.59 0.80–3.16
Antibiotic treatmentd 44/61 (72) 89/110 (81) 0.90 0.45–1.80
Drain 14/62 (23) 14/131 (11) 2.44 1.08–5.50
Intubation 22/65 (34) 19/131 (15) 3.02 1.49–6.12
Operation 21/63 (33) 38/131 (29) 1.22 0.64–2.33
Charlson score: (n¼ 182)
0–1 23 41 Reference
2–3 27 42 1.15 0.57–2.32
4–10 7 42 0.30 0.12–0.77
Karnovsky score: (n¼ 122)
10–40 16 19 Reference
50–60 14 30 0.55 0.22–1.39
65–90 19 24 0.94 0.38–2.31
Institution type: (n¼ 258)
University hospitals 62 102 Reference
Community hospitals 21 11 3.14 1.42–6.95
Long-term care and rehabilitation centers 7 55 0.21 0.09–0.49
Values shown in bold are significant.
aData were not available for all cases.
b95% confidence interval.
cOperative and non-operative wound.
dDuring this hospitalization and 3 weeks before.
Table 2 Independent risk factors for colonization/infection with a sporadic strain of MRSA versus a predominant clone:
stepwise logistic regression model
Sporadic Predominant Odds ratio CI95
a
Origin (%):
Home 36/79 (46%) 75/114 (66%) Reference
Nursing home 6/79 (8%) 12/114 (11%) 0.65 0.14–3.09
Transfer from Swiss hospital 12/79 (15%) 21/114 (18%) 0.66 0.15–2.91
Transfer from foreign hospital 25/79 (32%) 46/114 (5%) 42.49 5.02–359.6
Previous acquisition of MRSA 81/101 99/165 1.67 0.64–4.41
Drain 14/62 14/131 0.78 0.19–3.23
Intubation 22/65 19/131 1.98 0.60–6.60
Charlson score: (n¼ 182)
0–1 23 41 Reference
2–3 27 42 2.03 0.81–5.05
4–10 7 42 0.45 0.13–1.52
Institution type: (n¼ 258)
University hospitals 62 102 Reference
Community hospitals 21 11 1.12 0.19–6.83
Long-term care and rehabilitation centers 7 55 1.29 0.38–4.43
Values shown in bold are significant.
a95% confidence interval.
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Some sporadic isolates showing related patterns to
other European epidemic clones were recovered in
Switzerland (Figure 3). One strain, related to UK
EMRSA 15, was isolated in a community hospital,
and strains related to the South German clone [4]
were recovered in 12 patients from eight hospitals.
D I S C U S S I O N
The results of molecular typing of Swiss MRSA
isolates disclosed that the majority of isolates
belonged to a few predominant clones, whereas
the remaining isolates showed a great genetic
diversity, a situation that has been already describ-
ed in other hospitals or countries [7,8,26,27]. In
addition, the present study shows that there was
no difference between patients with predominant
or sporadic strains regarding underlying diseases
and other demographic or co-morbidity factors,
except for their location prior to admission. Based
on our study, we postulate that cases with spora-
dic strains became colonized either in foreign
hospitals or during a previous hospitalization in
Switzerland, whereas cases with predominant
clones acquired their strains mainly in relation
to the local spread of these clones within a given
Figure 2 Geographical dissemination of the three predo-
minant clones of MRSA in Switzerland in 1997 (one symbol
per institution and per clone; the number in the symbol
indicates the number of cases harboring the clone in the
institution).
Figure 3 PFGE patterns (analyzed
with the program GELCOMPAR) of
European epidemic MRSA related
to the four predominant Swiss
clones and to some sporadic Swiss
strains.
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hospital. Indeed, given the relatively low fre-
quency of MRSA observed in the present study,
and the fact that most cases admitted with MRSA
had been hospitalized previously, it seems unli-
kely that there is an important circulation of MRSA
in the community.
The genetic relatedness of the predominant
clones (with the exception of clone GE3) and of
some sporadic isolates to European epidemic
MRSA clones strongly suggests that they may have
been imported from surrounding countries. The
high diversity of sporadic strains suggests that
new strains are continuously imported from out-
side the country. At least one-third of these strains
were definitely imported during the transfer of the
patients from a foreign hospital. The origin of the
other two-thirds remains speculative. Previous
hospitalization in a foreign country and the immi-
gration of staff members from highly endemic
areas probably account for a substantial number
of cases, as already suggested [5,11,28]. One can
speculate that during the dissemination of a strain,
the accumulation of mutations allows the diversi-
fication of the genome. This genomic micro-
evolution is probably detected by the highly
discriminant typing method used in this study
(PFGE) [29]. Thus, most of these highly diverse
strains might be descended from a few ancestors.
Using a typing method that is able to keep track of
ancestors (multiprimer random amplification
polymorphism DNA), we have shown that all of
the Swiss isolates were related to other European
epidemic MRSA clones [30]. Thus, even in the cent-
ral and eastern parts of Switzerland where no
predominant clone was present, most of the MRSA
isolates probably originated from surrounding
countries, and were presumably imported either
through patients or through staff migration.
The three clones from Geneva (GE1, GE2 and
GE3) were mainly restricted to the Geneva uni-
versity hospitals. In contrast, the predominance of
the clone WCH could not be explained only by the
lack of MRSA control measures since they were
implemented before the first detection of this
clone. This clone was first isolated in Switzerland
in 1995, was responsible for several outbreaks in
1995–6 [16], and its spread continued during the
present study in 23 hospitals in which control
measures were implemented. It was found to be
identical to the Belgium epidemic clone 2 [23] and
related to an Ontario epidemic clone [24]. Some
intrinsic factors might be responsible for this
higher capacity for spreading. Interestingly, this
widespread clone was only present with a few
cases in Geneva hospitals.
In conclusion, a great diversity of MRSA strains
was found in Switzerland, suggesting that they
were imported either through patients or through
staff migration. However, transmission within and
between Swiss hospitals also occurred, as suggest-
ed by the fact that 65% of MRSA cases were due to
four predominant clones. Although there was no
epidemiological difference between patients with
a predominant or a sporadic MRSA strain, the use
of a typing method, preferably molecular, and
contributes to a better understanding of the intra-
and interhospital epidemiology, and thus to base
prevention and education on precise data.
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